LATEST APPSGONEFREE Follow us on twitter
GearAdvice AppAdvice/TV NowGaming WatchAware

Rejoyn is authorized by the FDA for adults age 22+ who want to add to their antidepressant medication

Rejoyn™

by Otsuka Precision Health, Inc.

What is it about?

Rejoyn is authorized by the FDA for adults age 22+ who want to add to their antidepressant medication. Over the course of 6 weeks, Rejoyn delivers proven brain-training exercises and short skills-based therapy lessons. Unlike wellness apps, Rejoyn was studied in a phase 3 clinical trial and is classified as a medical device. Rejoyn requires a prescription from a healthcare provider.

App Details

Version
1.2.2
Rating
(6)
Size
308Mb
Genre
Medical
Last updated
September 11, 2024
Release date
August 5, 2024
More info

App Screenshots

App Store Description

Rejoyn is authorized by the FDA for adults age 22+ who want to add to their antidepressant medication. Over the course of 6 weeks, Rejoyn delivers proven brain-training exercises and short skills-based therapy lessons. Unlike wellness apps, Rejoyn was studied in a phase 3 clinical trial and is classified as a medical device. Rejoyn requires a prescription from a healthcare provider.

The brain-training exercises in Rejoyn were developed and studied by a team of psychologists, psychiatrists, and neuroscientists. In a clinical trial, adding Rejoyn to antidepressant medication reduced depression symptoms with zero side effects related to Rejoyn. The exercises and lessons in Rejoyn tap into the brain's natural ability to change, known as neuroplasticity. You can think of it like physical therapy, but for your brain. Using Rejoyn for less than 2 hours per week for 6 weeks is designed to change how the brain works, which can improve depression symptoms.

Interested in trying Rejoyn?
Rejoyn must be prescribed by a healthcare provider. Talk to your provider about Rejoyn or learn how you can consult with a provider online at www.rejoyn.com.

Already have a prescription?
Download the app to get started. Once Rejoyn is downloaded, the app will guide you through setting up your account.

For more information, visit www.rejoyn.com.

See Patient Instructions for Use at https://www.rejoyn.com/Patient-Instructions-for-Use.pdf.

INDICATION: Rejoyn is a prescription digital therapeutic for the treatment of Major Depressive Disorder (MDD) symptoms as an adjunct to clinician-managed outpatient care for adult patients with MDD age 22 years and older who are on antidepressant medication. It is intended to reduce MDD symptoms.

SAFETY INFORMATION: Rejoyn is not intended to be used as a standalone treatment. Rejoyn does not replace your current medication, including medication for treatment of MDD. You should continue your current treatment as directed by your healthcare provider.

Rejoyn cannot send alerts or warnings to your healthcare provider. If you feel that your depression symptoms are worsening or if you have feelings or thoughts of harming yourself or others, please contact your healthcare provider, dial 911, or go to the nearest emergency room immediately.

To review the developer’s Privacy Policy, visit www.rejoyn.com/App-Privacy-Policy.

© 2024 Otsuka Precision Health, Inc. All rights reserved.

August 2024 20US23EBC0053

Disclaimer:
AppAdvice does not own this application and only provides images and links contained in the iTunes Search API, to help our users find the best apps to download. If you are the developer of this app and would like your information removed, please send a request to takedown@appadvice.com and your information will be removed.